Estimating the Undetected Burden of Respiratory Syncytial Virus Hospitalizations in Adults Through Capture-Recapture Methods.
RSV
capture–recapture
hospitalizations
respiratory syncytial virus
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
revised:
09
04
2024
received:
19
02
2024
accepted:
10
04
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
3
5
2024
Statut:
ppublish
Résumé
Traditional surveillance systems may underestimate the burden caused by respiratory syncytial virus (RSV). Capture-recapture methods provide alternatives for estimating the number of RSV-related hospitalizations in a population. Capture-recapture methods were used to estimate the number of RSV-related hospitalizations in adults in Middle Tennessee from two independent hospitalization surveillance systems during consecutive respiratory seasons from 2016-2017 to 2019-2020. Data from the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) and the Emerging Infections Program (EIP) were used. Annual RSV hospitalization rates were calculated using the capture-recapture estimates weighted by hospitals' market share divided by the corresponding census population. Using capture-recapture methods, the estimated overall adult hospitalization rates varied from 8.3 (95% CI: 5.9-15.4) RSV-related hospitalizations per 10,000 persons during the 2016-2017 season to 28.4 (95% CI: 18.2-59.0) hospitalizations per 10,000 persons in the 2019-2020 season. The proportion of hospitalizations that HAIVEN determined ranged from 8.7% to 36.7% of the total capture-recapture estimated hospitalization, whereas EIP detected 23.5% to 52.7% of the total capture-recapture estimated hospitalizations. Capture-recapture estimates showed that individual traditional surveillance systems underestimated the hospitalization burden in adults. Using capture-recapture allows for a more comprehensive estimate of RSV hospitalizations.
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13299Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002243
Pays : United States
Organisme : NIH HHS
ID : K24AI148459
Pays : United States
Organisme : CDC HHS
ID : CK17-1701
Pays : United States
Organisme : CDC HHS
ID : IP15-002
Pays : United States
Organisme : CDC HHS
ID : U01IP000979
Pays : United States
Informations de copyright
© 2024 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Références
“Respiratory Syncytial Virus Infection (RSV) [Internet],” cited June 6, 2023, https://www.cdc.gov/rsv/index.html.
H. K. Talbot and A. R. Falsey, “The Diagnosis of Viral Respiratory Disease in Older Adults,” Clinical Infectious Diseases 50, no. 5 (2010): 747–751.
K. Widmer, M. R. Griffin, Y. Zhu, J. V. Williams, and H. K. Talbot, “Respiratory Syncytial Virus‐ and Human Metapneumovirus‐Associated Emergency Department and Hospital Burden in Adults,” Influenza and Other Respiratory Viruses 8, no. 3 (2014): 347–352.
K. S. Ivey, K. M. Edwards, and H. K. Talbot, “Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults,” Journal of the American College of Cardiology 71, no. 14 (2018): 1574–1583.
A. C. Howa, Y. Zhu, D. Wyatt, et al., “Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using Capture‐Recapture,” The Journal of Infectious Diseases (2023): jiad417, https://doi.org/10.1093/infdis/jiad417.
“TN Department of Health [Internet],” cited Oct 27, 2023, Hospital Discharge Data System, https://www.tn.gov/health/health‐program‐areas/statistics/special‐reports/hdds.html.
A. R. Branche, “Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians,” Clinical Infectious Diseases 69, no. 2 (2019): 204–206.
“RSV‐NET Interactive Dashboard [Internet],” https://www.cdc.gov/rsv/research/rsv‐net/dashboard.html.
A. R. Branche, L. Saiman, E. E. Walsh, et al., “Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017‐2020,” Clinical Infectious Diseases 74, no. 6 (2022): 1004–1011.
K. Widmer, Y. Zhu, J. V. Williams, M. R. Griffin, K. M. Edwards, and H. K. Talbot, “Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults,” The Journal of Infectious Diseases 206, no. 1 (2012): 56–62.
G. Matias, R. Taylor, F. Haguinet, C. Schuck‐Paim, R. Lustig, and V. Shinde, “Estimates of Hospitalization Attributable to Influenza and RSV in the US During 1997‐2009, by Age and Risk Status,” BMC Public Health 17, no. 1 (2017): 271.
Z. Zheng, J. L. Warren, E. D. Shapiro, V. E. Pitzer, and D. M. Weinberger, “Estimated Incidence of Respiratory Hospitalizations Attributable to RSV Infections Across Age and Socioeconomic Groups,” Pneumonia (Nathan). 14, no. 1 (2022): 6.
D. L. McClure, B. A. Kieke, M. E. Sundaram, et al., “Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults ≥50 Years Old,” PLoS ONE 9, no. 7 (2014): e102586.
S. Cocchio, G. M. Prandi, P. Furlan, et al., “Respiratory Syncytial Virus in Veneto Region: Analysis of Hospital Discharge Records From 2007 to 2021,” International Journal of Environmental Research and Public Health 20, no. 5 (2023): 4565.
A. R. Falsey, P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh, “Respiratory Syncytial Virus Infection in Elderly and High‐Risk Adults,” The New England Journal of Medicine 352, no. 17 (2005): 1749–1759.
J. S. Nguyen‐van‐Tam, M. O'Leary, E. T. Martin, et al., “Burden of Respiratory Syncytial Virus Infection in Older and High‐Risk Adults: A Systematic Review and Meta‐Analysis of the Evidence From Developed Countries,” European Respiratory Review 31, no. 166 (2022): 220105.
M. Savic, Y. Penders, T. Shi, A. Branche, and J. Y. Pirçon, “Respiratory Syncytial Virus Disease Burden in Adults Aged 60 Years and Older in High‐Income Countries: A Systematic Literature Review and Meta‐Analysis,” Influenza and Other Respiratory Viruses 17, no. 1 (2023): e13031.